DARIFENACIN Pharmacologic Class Indexing
- Class set ID
- 8214a75f-0b59-45d7-bdbf-9a7619f0de0b
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval:2004 | Torrent Pharmaceuticals Limited | Torrent Pharma, Inc | 20260210 | 10 |
| These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval:2004 | Bryant Ranch Prepack | 20251117 | 100 |
| These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval:2004 | Bryant Ranch Prepack | 20251117 | 100 |
| These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004 | Cipla USA Inc. | CIPLA LIMITED PATALGANGA | 20251027 | 9 |
| These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004 | Aurobindo Pharma Limited | 20240419 | 5 |
| These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004 | Rising Pharma Holdings, Inc. | Aurobindo Pharma Limited | 20240419 | 2 |
| These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004 | Alembic Pharmaceuticals Limited | 20230130 | 3 |
| These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004 | Macleods Pharmaceuticals Limited | 20230125 | 4 |
| These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004 | POLYGEN PHARMACEUTICALS INC. | 20221201 | 3 |
| These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004 | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited | 20211213 | 8 |
| These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 2004 | Xiromed, LLC | Xiromed Pharma España, S.L | AustarPharma, LLC | 20210430 | 1 |
| These highlights do not include all the information needed to use DARIFENACIN extended-release tablets safely and effectively. See full prescribing information for DARIFENACIN extended-release tablets. DARIFENACIN extended-release tablets Initial U.S. Approval: 2004 | Alan Laboratories, Inc. | 20200409 | 5 |
| ENABLEX ® (darifenacin) Extended -release tablets Rx only Prescribing Information | Physicians Total Care, Inc. | 20100101 | 1 |